Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid

HAS ŞİMŞEK D., KUYUMCU S., AGAOGLU F., ÜNAL S. N.

CLINICAL NUCLEAR MEDICINE, cilt.44, sa.9, ss.764-766, 2019 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 44 Sayı: 9
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1097/rlu.0000000000002645
  • Dergi Adı: CLINICAL NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.764-766
  • Anahtar Kelimeler: adenoid cystic carcinoma, Ga-68-PSMA, Lu-177-PSMA, MEMBRANE ANTIGEN
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

In vivo prostate-specific membrane antigen (PSMA) overexpression creates an opportunity for PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid. Herein, we illustrate a patient with metastatic PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid who had intense PSMA uptake on metastatic lesions, followed by radionuclide therapy with Lu-177-PSMA.